Veeva Vault CRM Live at 125+ Biopharma Customers Across US, Europe, Japan
More than 125 customers across top 20 biopharmas in the U.S., Europe and Japan are now live on Vault CRM, driving Veeva's leadership in agentic CRM for life sciences. The company has moved its legacy CRM end-of-support to December 2029 and is embedding Veeva AI to enhance engagement workflows.
1. Vault CRM Adoption Milestone
Vault CRM has been deployed by more than 125 customers, including multiple top 20 biopharma firms across the U.S., Europe and Japan. The platform’s deep industry functionality, compliance features, workflows and embedded agents have driven strong uptake among commercial and medical teams.
2. Legacy CRM Support Extended
Veeva has advanced the end-of-support date for its legacy CRM from September 2030 to December 2029, offering a clear upgrade path to Vault CRM. This timeline adjustment aims to streamline customer migration and accelerate adoption of the next-generation platform.
3. AI Integration and Industry Impact
With Veeva AI now available within Vault CRM, the company is enhancing agentic automation across the product lifecycle, from market preparation and launch planning to mature brand optimization. This integrated AI capability is positioned to deepen customer engagement and drive greater ROI for life sciences organizations.